What Analysts Are Saying About Option Care Health Stock
9 analysts have expressed a variety of opinions on Option Care Health (NASDAQ:OPCH) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 6 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 2 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 2 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $36.67, a high estimate of $42.00, and a low estimate of $27.00. Surpassing the previous average price target of $34.75, the current average has increased by 5.53%.
Decoding Analyst Ratings: A Detailed Look
The perception of Option Care Health by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Petusky | Barrington Research | Raises | Outperform | $42.00 | $38.00 |
| Erin Wright | Morgan Stanley | Raises | Overweight | $38.00 | $35.00 |
| Constantine Davides | Citizens | Raises | Market Outperform | $38.00 | $36.00 |
| Raj Kumar | Stephens & Co. | Announces | Overweight | $40.00 | - |
| Kevin Fischbeck | B of A Securities | Raises | Buy | $35.00 | $32.00 |
| Pito Chickering | Deutsche Bank | Raises | Buy | $36.00 | $31.00 |
| Charles Rhyee | TD Cowen | Lowers | Hold | $27.00 | $30.00 |
| Constantine Davides | Citizens | Lowers | Market Outperform | $36.00 | $38.00 |
| Michael Petusky | Barrington Research | Maintains | Outperform | $38.00 | $38.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Option Care Health. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Option Care Health compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Option Care Health's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Option Care Health's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Option Care Health analyst ratings.
Delving into Option Care Health's Background
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Option Care Health: Delving into Financials
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Option Care Health displayed positive results in 3M. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately 12.24%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Option Care Health's net margin is impressive, surpassing industry averages. With a net margin of 3.61%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.81%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Option Care Health's ROA stands out, surpassing industry averages. With an impressive ROA of 1.51%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Option Care Health's debt-to-equity ratio stands notably higher than the industry average, reaching 0.94. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: What Are They?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.